Pluri (PLUR) Cash from Financing Activities (2010 - 2025)
Pluri (PLUR) reported Cash from Financing Activities of -$435000.0 for Q2 2025, down 4250.0% quarter-over-quarter from -$10000.0 in Q2 2023.
Pluri (PLUR) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 14 years of Cash from Financing Activities data on file, last reported at -$435000.0 in Q2 2025.
- Cash from Financing Activities for Q2 2025 came in at -$435000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $1.9 million (changed N/A YoY), and the FY2025 annual result was $9.5 million, up 7.83% from the prior year.
- Cash from Financing Activities retreated to -$435000.0 in Q2 2025 per PLUR's latest filing, from -$10000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $35.7 million in Q1 2021 and troughed at -$435000.0 in Q2 2025.
- A 3-year average of $12.4 million and a median of $2.3 million in 2023 frame the typical range for Cash from Financing Activities.
- On a YoY basis, Cash from Financing Activities climbed as much as 561.87% in 2021 and fell as far as 50.69% in 2021.
- A 3-year view of Cash from Financing Activities shows it stood at $24.4 million in 2021, then sank by 100.04% to -$10000.0 in 2023, then tumbled by 4250.0% to -$435000.0 in 2025.
- Business Quant data shows PLUR's Cash from Financing Activities at -$435000.0 in Q2 2025, -$10000.0 in Q2 2023, and $2.3 million in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 53,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 85,464.43 |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -435,000.00 |
| Jun 30, 2025 | -435,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | 2.34 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Jun 30, 2021 | 24.41 Mn |
| Jun 30, 2021 | 24.41 Mn |
| Mar 31, 2021 | 35.71 Mn |
| Mar 31, 2021 | 35.71 Mn |
| Dec 31, 2020 | 984,000.00 |
| Dec 31, 2020 | 984,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 49.51 Mn |
| Jun 30, 2020 | 49.51 Mn |
| Mar 31, 2020 | 5.40 Mn |
| Mar 31, 2020 | 5.40 Mn |
| Dec 31, 2019 | 3.99 Mn |
| Dec 31, 2019 | 3.99 Mn |